Relevant bibliographies by topics / 625.717.02 (043.2)

Contents

  1. Journal articles

Academic literature on the topic '625.717.02 (043.2)'

Author: Grafiati
Published: 30 May 2022
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '625.717.02 (043.2).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "625.717.02 (043.2)"

1

Musicus, Aviva A., Christina A. Roberto, Alyssa J. Moran, Sarah Sorscher, Eva Greenthal, and Eric B. Rimm. "Effect of Front-of-Package Information, Fruit Imagery, and High–Added Sugar Warning Labels on Parent Beverage Choices for Children." JAMA Network Open 5, no. 10 (2022): e2236384. http://dx.doi.org/10.1001/jamanetworkopen.2022.36384.

Full text
Abstract:
ImportanceFruit drinks are widely consumed by young children, and many parents mistakenly believe that these drinks are healthy, potentially due to front-of-package claims and imagery. Research is needed on the influence of this marketing and how labeling regulations could change behavior.ObjectiveTo assess the effects of a front-of-package 100% vitamin C claim, fruit imagery, percentage juice and teaspoons of added sugar disclosures, and high–added sugar warnings on parents’ choices, knowledge, and perceptions of beverages.Design, Setting, and ParticipantsThis randomized clinical trial was co
APA, Harvard, Vancouver, ISO, and other styles
2

Álvarez-Reguera, C., J. J. Gaitán-Valdizán, R. Fernández-Ramón, et al. "POS0740 EPIDEMIOLOGY AND CLINICAL FEATURES OF OCULAR SARCOIDOSIS. STUDY OF 65 PATIENTS OF A SERIES OF 384 PATIENTS FROM A SINGLE UNIVERSITY HOSPITAL." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 621.2–622. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1930.

Full text
Abstract:
Background:Ocular involvement in sarcoidosis can be present in up to 80% of patients. If not treated, it can lead to significant visually complications (1-5).Objectives:Our aim was to assess the main a) epidemiology and b) clinical features of ocular sarcoidosis in a wide and unselected series from a single university hospital.Methods:Study of a large cohort (n=384) of all consecutive patients diagnosed with sarcoidosis from January 1, 1999 to December 31, 2019. Finally, 344 patients were included according to the ATS/ERS/WASOG criteria (Eur Respir J. 1999;14:735-7).Results:65 (33 men/32 women
APA, Harvard, Vancouver, ISO, and other styles
3

Iovoli, Austin J., Lauren Turecki, Michelle L. Qiu, et al. "Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer." JAMA Network Open 6, no. 10 (2023): e2337265. http://dx.doi.org/10.1001/jamanetworkopen.2023.37265.

Full text
Abstract:
ImportanceOral mucositis (OM) is a common and debilitating adverse effect observed in patients with head and neck cancer (HNC) receiving radiation therapy (RT). Previous studies examining associations between OM and clinical outcomes were performed in the era of 3-dimensional conformal RT planning with low rates of concurrent chemotherapy, and thus may not reflect current practice.ObjectiveTo prospectively assess patient-reported OM and identify its associations with clinical outcomes and quality of life.Design, Setting, and ParticipantsThis cohort study performed at a single institution inclu
APA, Harvard, Vancouver, ISO, and other styles
4

Álvarez-Reguera, C., J. J. Gaitán-Valdizán, R. Fernández-Ramón, et al. "OP0091 TREATMENT OF OCULAR SARCOIDOSIS. STUDY OF 65 PATIENTS OF A SERIES OF 384 PATIENTS FROM A SINGLE UNIVERSITY HOSPITAL." Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 50.1–50. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1896.

Full text
Abstract:
Background:Ocular involvement is a relatively frequent and potentially severe complication of sarcoidosis. Oral corticosteroids (OCS) are the first-line treatment. Conventional immunosuppressive agents (cIS) and biological therapy (BT) can be used in refractory cases (1-5).Objectives:To evaluate the treatment and visual outcomes of a cohort of patients diagnosed with ocular sarcoidosis.Methods:Study of a large cohort (n=384) of all consecutive patients diagnosed with sarcoidosis from January 1, 1999 to December 31, 2019 at a single University Hospital. Finally, 344 patients were included accor
APA, Harvard, Vancouver, ISO, and other styles
5

He, Mei, Junjie Chen, Xuan Yao, et al. "First report of Fusarium acuminatum causing white fruit disease of Mulberry in China." Plant Disease, June 2, 2025. https://doi.org/10.1094/pdis-02-25-0382-pdn.

Full text
Abstract:
Mulberry (Morus alba L.) is an excellent fruit tree species, which is widely planted all over China. In April 2023, a white fruit disease was observed on Mulberry plants in Hunan Province (27°22'13.80"N, 112°1'32.19"E), China. The disease incidence was nearly 50% in a surveyed area of 2000 m2, which contained nearly 400 plants. Symptoms appeared on the fruit, which was grayish white, with dark brown spots on the surface, and the small fruit core was dehydrated. A total of 20 symptomatic samples were randomly collected. To identify the pathogen, symptomatic fruit tissues (0.3 cm × 0.3 cm) from
APA, Harvard, Vancouver, ISO, and other styles
6

Fox, John Leonard, Scott Spencer, Damon Hostin, et al. "Health care resource utilization (HCRU) and costs in insured patients with advanced lung cancer with or without clinical trial participation (CTP)." Journal of Clinical Oncology 43, no. 16_suppl (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.e13526.

Full text
Abstract:
e13526 Background: Clinical trials are often recommended for cancer treatment, but CTP remains low. CTP barriers may include higher costs to the patient or health plan. This study aimed to compare HCRU and costs for insured patients with advanced lung cancer with or without CTP. Methods: This retrospective cohort study used de-identified administrative claims data from commercial (COM) and Medicare Advantage (MA) enrollees in the Optum Labs Data Warehouse. Patients were identified in claims from 01/01/2018 to 02/28/2022 with ≥2 diagnoses ≥30 days apart for lung cancer, no other primary cancers
APA, Harvard, Vancouver, ISO, and other styles
7

Sonikian, Makrouhi, Aikaterinh Velentza, Theodoros Chiras, et al. "MO805: Combination of Conventional Haemodialysis with Haemoperfusion: Does it Provide any Benefits to Haemodialysis Patients?" Nephrology Dialysis Transplantation 37, Supplement_3 (2022). http://dx.doi.org/10.1093/ndt/gfac082.003.

Full text
Abstract:
Abstract BACKGROUND AND AIMS Conventional haemodialysis (HD) with low-flux membranes does not provide adequate middle molecular weight (MMW) clearance of uremic toxins [1]. The potential for better removal of parathyroid hormone (PTH) and β2-microglobulin (β2M) was investigated using a combination of low-flux HD and haemoperfusion (HP) (HD + HP). METHOD A total of 16 stable HD male patients, free of infections, malignancies or haematological disorders, under usual medications for anaemia and hyperparathyroidism, treated with low-flux polysulfone membranes, were randomized into two groups: grou
APA, Harvard, Vancouver, ISO, and other styles
8

Lee, Yong-Joon, Bum-Kee Hong, Kyeong Ho Yun, et al. "Alternative LDL Cholesterol–Lowering Strategy vs High-Intensity Statins in Atherosclerotic Cardiovascular Disease." JAMA Cardiology, November 20, 2024. http://dx.doi.org/10.1001/jamacardio.2024.3911.

Full text
Abstract:
ImportanceIn patients with atherosclerotic cardiovascular disease (ASCVD), intensive lowering of low-density lipoprotein (LDL) cholesterol levels with high-intensity statins is generally recommended. However, alternative approaches considering statin-related adverse effects and intolerance are needed.ObjectiveTo compare the long-term efficacy and safety of an alternative LDL cholesterol–lowering strategy vs high-intensity statin strategy in patients with ASCVD in randomized clinical trials.Data SourcesPubMed, Embase, and other websites (ClinicalTrials.gov, European Society of Cardiology, tctMD
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography